Author

N. S. Haddad

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Assay:flow cytometry· 1 Assay:metabolomics· 1

Frequent Co-Authors

F. E.-H. Lee· 3 shared H. Wu· 2 shared M. E. Kuruvilla· 2 shared R. P. Ramonell· 2 shared A. Bressler· 1 shared A. Derrico· 1 shared A. Kosters· 1 shared A. Morrison-Porter· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

F. E.-H. Lee

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Inactivation of SARS Coronavirus 2 and COVID-19 patient samples for contemporary immunology and metabolomics studies

D. J. Eddins, L. C. Bassit, J. Chandler, N. S. Haddad, K. Musall, J. Yang, A. Kosters, B. S. Dobosh, M. R. Hernandez, R. P. Ramonell, R. M. Tirouvanziam, F. E.-H. Lee, K. Zandi, R. F. Schinazi, E. Ghosn

This paper demonstrates optimal viral inactivation methods for SARS-CoV-2 and COVID-19 patient samples to enable safe handling at lower biosafety levels while preserving downstream assay fidelity.

bioRxiv · Oct 22, 2021Microbiology

Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection

N. S. Haddad, D. C. Nguyen, M. E. Kuruvilla, A. Morrison-Porter, F. Anam, K. S. Cashman, R. P. Ramonell, S. Kyu, A. S. Saini, M. Cabrera-Mora, A. Derrico, D. Alter, J. D. Roback, M. Horwath, J. B. O'Keefe, , F. E.-H. Lee

This paper develops a multiplex immunoassay to measure SARS-CoV-2 antibody responses and finds that severe COVID-19 is associated with higher early antibody levels against S1 and N proteins.

bioRxiv · Dec 4, 2020 · PreprintImmunology

Novel Immunoassay for Diagnosis of Ongoing Clostridioides difficile Infections Using Serum and Medium Enriched for Newly Synthesized Antibodies (MENSA)

N. S. Haddad, S. Nozick, G. Kim, S. Ohanian, C. S. Kraft, P. A. Rebolledo, Y. F. Wang, H. Wu, A. Bressler, S. N. T. Le, M. E. Kuruvilla, L. E. Cannon, F. E.-H. Lee, J. Daiss

This study develops a multiplex immunoassay using serum and MENSA to diagnose active CDI, finding that combining both methods improves detection compared to using either alone.

bioRxiv · Apr 23, 2020Microbiology